JP2012025752A5 - - Google Patents

Download PDF

Info

Publication number
JP2012025752A5
JP2012025752A5 JP2011177452A JP2011177452A JP2012025752A5 JP 2012025752 A5 JP2012025752 A5 JP 2012025752A5 JP 2011177452 A JP2011177452 A JP 2011177452A JP 2011177452 A JP2011177452 A JP 2011177452A JP 2012025752 A5 JP2012025752 A5 JP 2012025752A5
Authority
JP
Japan
Prior art keywords
antibody
disease
medicament
seq
hgf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011177452A
Other languages
English (en)
Japanese (ja)
Other versions
JP5554298B2 (ja
JP2012025752A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012025752A publication Critical patent/JP2012025752A/ja
Publication of JP2012025752A5 publication Critical patent/JP2012025752A5/ja
Application granted granted Critical
Publication of JP5554298B2 publication Critical patent/JP5554298B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2011177452A 2004-10-04 2011-08-15 肝細胞成長因子活性化物質のモジュレータ Expired - Fee Related JP5554298B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61565704P 2004-10-04 2004-10-04
US60/615,657 2004-10-04

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007535866A Division JP4937127B2 (ja) 2004-10-04 2005-10-03 肝細胞成長因子活性化物質のモジュレータ

Publications (3)

Publication Number Publication Date
JP2012025752A JP2012025752A (ja) 2012-02-09
JP2012025752A5 true JP2012025752A5 (https=) 2012-11-01
JP5554298B2 JP5554298B2 (ja) 2014-07-23

Family

ID=36148972

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007535866A Expired - Fee Related JP4937127B2 (ja) 2004-10-04 2005-10-03 肝細胞成長因子活性化物質のモジュレータ
JP2011177452A Expired - Fee Related JP5554298B2 (ja) 2004-10-04 2011-08-15 肝細胞成長因子活性化物質のモジュレータ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007535866A Expired - Fee Related JP4937127B2 (ja) 2004-10-04 2005-10-03 肝細胞成長因子活性化物質のモジュレータ

Country Status (15)

Country Link
US (4) US20060147451A1 (https=)
EP (1) EP1809673B1 (https=)
JP (2) JP4937127B2 (https=)
KR (1) KR101252306B1 (https=)
CN (1) CN101035810B (https=)
AU (1) AU2005294146B2 (https=)
BR (1) BRPI0515670A (https=)
CA (1) CA2577598C (https=)
ES (1) ES2398528T3 (https=)
IL (1) IL181450A0 (https=)
NO (1) NO20072302L (https=)
NZ (1) NZ553327A (https=)
RU (1) RU2418004C2 (https=)
WO (1) WO2006042173A2 (https=)
ZA (1) ZA200701789B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0515670A (pt) 2004-10-04 2008-07-29 Genentech Inc anticorpos isolados e método de tratamento de uma doença associada com descontrole da sinalização do hgf/c-met
US8088908B2 (en) * 2005-05-10 2012-01-03 City Of Hope Humanized anti-prostate stem cell antigen monoclonal antibody
DK2056874T3 (da) * 2006-08-21 2012-10-15 Hoffmann La Roche Tumorterapi med et anti-vegf-antistof
AR065271A1 (es) * 2007-02-09 2009-05-27 Genentech Inc Anticuerpos anti-robo4 y sus usos
US20170204191A1 (en) * 2008-10-06 2017-07-20 Cynthia C. Bamdad Muc1* antibodies
US20110206704A1 (en) * 2009-10-19 2011-08-25 Genentech, Inc. Methods and compositions for modulating hepatocyte growth factor activator
US8759491B2 (en) * 2009-10-19 2014-06-24 Genentech, Inc. Modulators of hepatocyte growth factor activator
EP2491059B1 (en) 2009-10-22 2015-02-25 F.Hoffmann-La Roche Ag Anti-hepsin antibodies and methods using same
MX346500B (es) 2010-11-10 2017-03-22 Genentech Inc * Metodos y composiciones para inmunoterapia para enfermedad neural.
EP3221361B1 (en) 2014-11-19 2021-04-21 Genentech, Inc. Anti-transferrin receptor / anti-bace1 multispecific antibodies and methods of use
WO2016081639A1 (en) 2014-11-19 2016-05-26 Genentech, Inc. Antibodies against bace1 and use thereof for neural disease immunotherapy
CA2976089C (en) 2015-02-10 2026-01-13 Minerva Biotechnologies Corporation Humanized anti-muc1* antibodies
WO2023172863A1 (en) * 2022-03-07 2023-09-14 Elixiron Immunotherapeutics (hong Kong) Limited Anti-cd36 antibodies and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1400536A1 (en) * 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
CA2102463A1 (en) * 1992-11-05 1994-05-06 Mitsubishi Chemical Corporation Protein and gene encoding said protein
US6309636B1 (en) * 1995-09-14 2001-10-30 Cancer Research Institute Of Contra Costa Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
US7045602B2 (en) * 2000-12-05 2006-05-16 Mitsubishi Chemical Corporation Specific antibody directed to active hepatocyte growth factor activator and method for using the same
JP4090236B2 (ja) * 2000-12-05 2008-05-28 三菱化学株式会社 活性型肝細胞増殖因子アクティベーターに対する特異的抗体とその使用法
BRPI0515670A (pt) 2004-10-04 2008-07-29 Genentech Inc anticorpos isolados e método de tratamento de uma doença associada com descontrole da sinalização do hgf/c-met

Similar Documents

Publication Publication Date Title
JP2012025752A5 (https=)
NZ626269A (en) Anti-phf-tau antibodies and their uses
UY33407A (es) Anticuerpos específicos del factor gdf8 humano
LTPA2017040I1 (lt) Antikūnai prieš CD38 antigeną, skirti išsėtinės mielomos gydymui
UA104626C2 (ru) Анти-vegf антитело и его применение
HUE046222T2 (hu) Gyermekkori akut limfoblasztos leukémia kezelése bispecifikus, CD3XCD19 elleni ellenanyagokkal
MX375113B (es) Anticuerpos que se unen específicamente a la toxina alfa de staphylococcus aureus y métodos de uso.
JO3118B1 (ar) تراكيب وطرق لبروتين c5 المتمم يستهدف الأجسام المضادة
AR096895A2 (es) Anticuerpo que se une a la citoquina, linfopoyetina estromal tímica (tslp)
DK2352763T4 (da) Bispecifikke enkeltkædede antistoffer med specificitet for højmolekylære målantigener
NZ602320A (en) Bispecific, bivalent anti-vegf/anti-ang-2 antibodies
NZ611076A (en) Anti-ngf compositions and use thereof
UY32603A (es) Inmunoglobulina con dominio variable dual y usos de la misma
LTPA2016030I1 (lt) Dauginės mielomos, naudojant kombinuotas terapijas, pagrįstas anti-CS1 antikūnais, gydymo būdai
CR11837A (es) Inmunoglobulinas con dominio variable dual y usos de la misma
EA201170716A1 (ru) Антитела к с-мет
NZ586053A (en) Anti-vegf antibody compositions and methods
EA201201357A1 (ru) Антитела к cd40
EA201891833A1 (ru) Комбинация для лечения амиотрофического бокового склероза или родственных болезней
UA113388C2 (xx) ЗАСТОСУВАННЯ АНТИТІЛА ПРОТИ с-МЕТ
DK2056874T3 (da) Tumorterapi med et anti-vegf-antistof
NZ599140A (en) Antibodies that specifically bind to the epha2 receptor
NL1032132A1 (nl) Nieuwe MAdCAM-antilichamen.
IN2012DN02521A (https=)
EA200900767A1 (ru) Антагонистические антитела против ephb3